News Novo Nordisk A/S

Equities

NOVO B

DK0062498333

Pharmaceuticals

Real-time Estimate Cboe Europe Other stock markets 07:28:22 2025-03-17 am EDT			5-day change	1st Jan Change
544.40 ^DKK	+2.68%		-0.69%	-12.59%

Mar. 14	Drugmakers agree to participate in second round of price negotiations	RE
Mar. 14	Drugmakers agree to participate in second round of price negotiations	RE

European shares kick off week higher; focus on German debt reform plans	06:20am	RE
AstraZeneca, Novo Nordisk, GSK Sign Up for Medicare Drug Price Negotiation in US	02:37am	MT
Drugmakers agree to participate in second round of price negotiations	Mar. 14	RE
Drugmakers agree to participate in second round of price negotiations	Mar. 14	RE
Drugmakers agree to participate in second round of price negotiations	Mar. 14	RE
CMS Announces Manufacturer Participation in Second Cycle of Medicare Drug Price Negotiation	Mar. 14	RE
NOVO NORDISK : UBS maintains a Buy rating	Mar. 14	ZD
DNB Health Care down 2.32 percent in February - divested holding in Pfizer	Mar. 14	FW
Oddo raises Novo Nordisk to outperform (neutral), target price DKK 720 - BN	Mar. 14	FW
Altimmune to test obesity drug for alcohol use disorder and related health conditions	Mar. 13	RE
Market Update-Europe ends under pressure with the threat of a trade war	Mar. 13	RE
European Equities Traded in the US as American Depositary Receipts Tread Water in Thursday Trading	Mar. 13	MT
Kepler Cheuvreux Upgrades Novo Nordisk to Buy, Lowers PT	Mar. 13	MT
European shares pare gains as trade war escalates	Mar. 13	RE
Kepler Cheuvreux raises Novo Nordisk to buy	Mar. 13	FW
Odin Norden fell 2.38 percent in February - many company acquisitions during the month	Mar. 13	FW
Kepler Cheuvreux upgrades Novo Nordisk to Buy (Hold), target price DKK 630 (715)	Mar. 13	FW
Health Care Down on Rotation Back to Risk -- Health Care Roundup	Mar. 12	DJ
Warburg Pincus, KKR in talks to buy medical packaging maker Gerresheimer, Bloomberg News reports	Mar. 12	RE
European Equities Traded in the US as American Depositary Receipts Lower Wednesday	Mar. 12	MT
NOVO NORDISK : Jefferies reiterates its Sell rating	Mar. 12	ZD
BofA Global Research Keeps Roche at Buy After 'Compelling' $5.3 billion Zealand Pharma Deal	Mar. 12	MT
Novo Nordisk falls after Roche's agreement with Zealand Pharma	Mar. 12	FW
Roche ups the ante in obesity	Mar. 12
Roche secures Zealand obesity drug candidate for up to $5.3 billion	Mar. 12	RE